Cardinal Health stock after-hours at EUR 202.90: minus 0.37 percent
Published on 10/02/2026 at 23:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cardinal Health traded at EUR 202.90 in after-hours trading at 10:59 p.m. CEST on October 2, 2026, down 0.37 percent versus the prior close at Lang & Schwarz.
After-hours trading
The prior close at Lang & Schwarz was EUR 203.65. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Cardinal Health stock.
CVS distribution agreement extended
On October 1, 2026, Cardinal Health announced that it had entered into a binding letter of intent with CVS Health to extend its existing pharmaceutical distribution agreement through June 30, 2032. The company said the extension would continue its current scope of distribution services. The announcement was published by Cardinal Health.
In connection with the renewal, Cardinal Health reaffirmed fiscal 2027 non-GAAP EPS growth guidance of 13 percent to 15 percent, equivalent to $12.40 to $12.60. It also reaffirmed long-term non-GAAP EPS growth guidance of 12 percent to 14 percent. The fiscal 2027 growth comparison is based on adjusted fiscal 2026 results excluding the fiscal 2026 benefit from an IEEPA tariff refund, according to the company's release.
First-quarter results scheduled for November 5
Cardinal Health said it plans to release fiscal 2027 first-quarter results on November 5, 2026, before trading opens on the New York Stock Exchange. The company plans to webcast a discussion of the results at 8:30 a.m. Eastern. The schedule was announced in a separate Cardinal Health release.
